datamatters24/research-document-archive huggingface dataset:
I
105TH CONGRESS
1ST SESSION
H. R. 1741
To amend the Internal Revenue Code of 1986 to allow taxpayers in the
process of adopting a child to use alternative information, rather than
a TIN, to claim the dependency exemption for the child.
IN THE HOUSE OF REPRESENTATIVES
MAY 22, 1997
Ms. PRYCE of Ohio introduced the following bill; which was referred to the
Committee on Ways and Means
A BILL
To amend the Internal Revenue Code of 1986 to allow tax-
payers in the process of adopting a child to use alter-
native information, rather than a TIN, to claim the
dependency exemption for the child.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. USE OF ALTERNATIVE INFORMATION, RATHER
THAN TIN, TO CLAIM DEPENDENCY EXEMP-
TION FOR CHILD IN PROCESS OF ADOPTION.
(a) IN GENERAL.—Subsection (e) of section 151 of
the Internal Revenue Code of 1986 (relating to allowance
of deductions for personal exemptions) is amended to read
as follows:
‘‘(e) IDENTIFYING INFORMATION REQUIRED.—
‘‘(1) Except as provided in paragraph (2), no
exemption shall be allowed under this section with
respect to any individual unless the TIN of such in-
dividual is included on the return claiming the ex-
emption.
‘‘(2) SPECIAL
RULES
FOR
INDIVIDUALS
IN
PROCESS OF ADOPTION.—In the case of an individ-
ual whom the taxpayer is in the process of adopting,
the taxpayer may substitute for the TIN required
under paragraph (1)—
‘‘(A) if such individual is a citizen or resi-
dent of the United States, the words ‘adoption
pending’ on the return and, attached to the re-
turn, a copy of documentation from an adoption
agency (or a legal authority) showing that the
individual was placed in the taxpayer’s home
for legal adoption,
‘‘(B) if such individual is not a citizen or
resident of the United States, an ITIN (as de-
fined by the Secretary in regulations), or
‘‘(C) such information as the Secretary
may specify with respect to such adoption.’’
(b) EFFECTIVE DATE.—The amendment made by
this section shall apply to taxable years ending after the
date of the enactment of this Act.
Æ
I
105TH CONGRESS
1ST SESSION
H. R. 1742
To suspend temporarily the duty on certain viscose rayon yarn.
IN THE HOUSE OF REPRESENTATIVES
MAY 22, 1997
Mr. ROTHMAN introduced the following bill; which was referred to the
Committee on Ways and Means
A BILL
To suspend temporarily the duty on certain viscose rayon
yarn.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. TEMPORARY SUSPENSION OF DUTY.
(a) IN GENERAL.—Subchapter II of chapter 99 of
the Harmonized Tariff Schedule of the United States is
amended by inserting in numerical sequence the following
new heading:
‘‘
9902.54.03
Artificial filament
yarn (other than
sewing thread) of
viscose rayon
(provided for in
subheading
5403.10.30,
5403.31.00, or
5403.32.00) .........
Free
No change
No change
On or before
12/31/2000
’’.
(b) EFFECTIVE DATE.—The amendment made by
subsection (a) applies with respect to goods entered, or
withdrawn from warehouse for consumption, on or after
the 15th day after the date of the enactment of this Act.
Æ
I
105TH CONGRESS
1ST SESSION
H. R. 1743
To amend the Internal Revenue Code of 1986 to repeal the limitations
on medical savings accounts relating to the number of accounts and
number of employees of an employer, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
MAY 22, 1997
Mr. SALMON (for himself, Mr. BOEHNER, Mr. HASTERT, Mr. STUMP, Mr.
NORWOOD, Mr. GOSS, Mrs. KELLY, Mr. WICKER, Mr. FOLEY, Mr.
COBURN, Mr. BARTLETT of Maryland, Mr. CANNON, Mr. DOOLITTLE,
Mr. MANZULLO, Mr. HOSTETTLER, Mr. LARGENT, Mr. BURTON of Indi-
ana, Mr. KOLBE, Mr. CAMPBELL, Mr. PAUL, Mr. MCCRERY, Mr. SES-
SIONS, Mr. COOKSEY, Mr. BUNNING of Kentucky, Mr. BRADY, Mr.
SHADEGG, 
Mr. 
ROYCE, 
Mr. 
BALLENGER, 
Mr. 
PAPPAS, 
Mr.
ROHRABACHER, Mr. HILLEARY, Mr. NUSSLE, Mr. HAYWORTH, Mr.
MCINTOSH, Mr. SMITH of New Jersey, Mr. CHABOT, Mr. ENSIGN, Mr.
HUTCHINSON, Mr. HOEKSTRA, Mr. TALENT, Mr. CUNNINGHAM, Mr.
SENSENBRENNER, Mr. BOB SCHAFFER, Mr. WHITE, Mr. SAM JOHNSON
of Texas, Mr. GRAHAM, Mr. EVERETT, Mr. SCARBOROUGH, Mr. CRAPO,
Mr. METCALF, Mr. MCKEON, Mr. NEUMANN, Mr. SKEEN, Mr. SOUDER,
and Mr. COMBEST) introduced the following bill; which was referred to
the Committee on Ways and Means
A BILL
To amend the Internal Revenue Code of 1986 to repeal
the limitations on medical savings accounts relating to
the number of accounts and number of employees of
an employer, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. REPEAL OF CERTAIN LIMITATIONS ON MEDI-
CAL SAVINGS ACCOUNTS.
(a) NUMBER OF TAXPAYERS HAVING MSAS.—Sec-
tion 220 of the Internal Revenue Code of 1986 is amended
by striking subsections (i) and (j).
(b) SIZE OF EMPLOYER.—Subsection (c) of section
220 of such Code is amended—
(1) in subclause (I) of paragraph (1)(A)(iii), by
striking ‘‘and such employer is a small employer’’,
(2) in paragraph (1), by striking subparagraphs
(C) and (D), and
(3) by striking paragraph (4) and redesignating
paragraph (5) as paragraph (4).
(c) EFFECTIVE DATE.—The amendments made by
subsections (a) and (b) shall take effect as if included in
the amendment made by section 301 of the Health Insur-
ance Portability and Accountability Act of 1996.
Æ
I
105TH CONGRESS
1ST SESSION
H. R. 1744
To make the antitrust laws applicable to owners of teams of major league
professional baseball players, and to leagues composed of such teams,
with respect to selecting the site at which any such team plays its
regular season home games.
IN THE HOUSE OF REPRESENTATIVES
MAY 22, 1997
Mr. SCHUMER (for himself and Mr. NADLER) introduced the following bill;
which was referred to the Committee on the Judiciary
A BILL
To make the antitrust laws applicable to owners of teams
of major league professional baseball players, and to
leagues composed of such teams, with respect to selecting
the site at which any such team plays its regular season
home games.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Freedom of Movement
for Baseball Teams Act of 1997’’.
SEC. 2. LIMITATION ON ANTITRUST IMMUNITY APPLICABLE
TO HOME LOCATIONS OF PROFESSIONAL
BASEBALL TEAMS.
An owner of all or part of a team of major league
professional baseball players shall not be immune to liabil-
ity under the antitrust laws for entering into, attempting
to enter into, performing, or enforcing a contract that is
made (or attempted to be made) by 2 or more owners of
teams of major league professional baseball players (or 2
or more leagues composed of such teams) and that pro-
vides for 1 or more of such owners (or 1 or more of such
leagues) to determine the location at which a team of
major league professional baseball players plays its regular
season home games.
SEC. 3. DEFINITION.
For purposes of this Act, the term ‘‘antitrust laws’’
has the meaning given it in subsection (a) of the first sec-
tion of the Clayton Act (15 U.S.C. 12(a)), except that
such term includes section 5 of the Federal Trade Com-
mission Act (15 U.S.C. 45) to the extent such section ap-
plies to unfair methods of competition.
Æ
108TH CONGRESS
2D SESSION
H. R. 4766
AN ACT
Making appropriations for Agriculture, Rural De-
velopment, Food and Drug Administration, and
Related Agencies for the fiscal year ending Sep-
tember 30, 2005, and for other purposes.
by striking ‘‘and up to $1,188,525 for the period begin-
ning on October 1, 2015, and ending on October 29, 
2015,’’ and inserting ‘‘and up to $2,090,164 for the period 
beginning on October 1, 2015, and ending on November 
20, 2015,’’. 
(e) 
NEW
ENTRANT
AUDITS.—Section 
31144(g)(5)(B) of title 49, United States Code, is amend-
ed by striking ‘‘and up to $2,535,519 for the period begin-
ning on October 1, 2015, and ending on October 29, 
2015,’’ and inserting ‘‘and up to $4,459,016 for the period 
beginning on October 1, 2015, and ending on November 
20, 2015,’’. 
(f) OUTREACH AND EDUCATION.—Section 4127(e) of 
SAFETEA–LU (119 Stat. 1741) is amended by striking 
‘‘and $316,940 to the Federal Motor Carrier Safety Ad-
ministration for the period beginning on October 1, 2015, 
and ending on October 29, 2015,’’ and inserting ‘‘and 
$557,377 to the Federal Motor Carrier Safety Adminis-
tration for the period beginning on October 1, 2015, and 
ending on November 20, 2015,’’. 
(g) GRANT PROGRAM FOR COMMERCIAL MOTOR VE-
HICLE OPERATORS.—Section 4134(c) of SAFETEA–LU 
(49 U.S.C. 31301 note) is amended by striking ‘‘and 
$79,235 for the period beginning on October 1, 2015, and 
ending on October 29, 2015,’’ and inserting ‘‘and
scribed in paragraph (1)(A), the Secretary shall take 
into account recommendations made by the National 
Academy of Medicine. 
(f) IMPROVING COORDINATION RELATED TO MINORITY 
HEALTH AND HEALTH DISPARITIES.—Section 464z–3 of 
the Public Health Service Act (42 U.S.C. 285t) is amend-
ed— 
(1) by redesignating subsection (h), relating to 
interagency coordination, that follows subsection (j) 
as subsection (k); and 
(2) in subsection (k) (as so redesignated)— 
(A) in the subsection heading, by striking 
‘‘INTERAGENCY’’ and inserting ‘‘INTRA-NATIONAL 
INSTITUTES OF HEALTH’’; 
(B) by striking ‘‘as the primary Federal of-
ficials’’ and inserting ‘‘as the primary Federal 
official’’; 
(C) by inserting a comma after ‘‘review’’; 
(D) by striking ‘‘Institutes and Centers of 
the National Institutes of Health’’ and inserting 
‘‘national research institutes and national cen-
ters’’; and 
(E) by adding at the end the following: 
‘‘The Director of the Institute may foster part-
nerships between the national research institutes
I
105TH CONGRESS
1ST SESSION
H. R. 1746
To provide that, in any year in which the Congress does not timely adopt
a concurrent resolution on the budget that eliminates the deficit by
fiscal year 2002, Members of Congress shall forfeit their right to be
paid for the remainder of that year.
IN THE HOUSE OF REPRESENTATIVES
MAY 22, 1997
Mr. SESSIONS introduced the following bill; which was referred to the
Committee on House Oversight
A BILL
To provide that, in any year in which the Congress does
not timely adopt a concurrent resolution on the budget
that eliminates the deficit by fiscal year 2002, Members
of Congress shall forfeit their right to be paid for the
remainder of that year.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. FORFEITURE OF PAY FOR FAILURE TO ADOPT
A TIMELY CONCURRENT RESOLUTION THAT
ACHIEVES A BALANCED BUDGET BY FISCAL
YEAR 2002.
Subsection (a) of section 601 of the Legislative Reor-
ganization Act of 1946 (2 U.S.C. 31) is amended by add-
ing at the end the following:
‘‘(3)(A) Notwithstanding any other provision of this
subsection, if, in any calendar year beginning after the
date of the enactment of this paragraph and before the
start of fiscal year 2002, Congress does not complete ac-
tion on a balanced budget resolution before June 16th of
such calendar year, no Member of Congress shall be enti-
tled to pay for service performed during any month in
such year that begins after that date.
‘‘(B) For purposes of this paragraph, the term ‘bal-
anced budget resolution’ means a concurrent resolution on
the budget (within the meaning of section 3 of the Con-
gressional Budget and Impoundment Control Act of 1974)
which eliminates the budget deficit by September 30,
2002.
‘‘(C) The amount of any pay forfeited under this
paragraph shall be returned to the Treasury, to be used
for deficit reduction.’’.
Æ
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘John F. Kennedy Cen-
ter Parking Improvement Act of 1997’’.
SEC. 2. PARKING GARAGE ADDITIONS AND SITE IMPROVE-
MENTS.
Section 3 of the John F. Kennedy Center Act (20
U.S.C. 76i) is amended—
(1) by striking the section heading and all that
follows through ‘‘The Board’’ and inserting the fol-
lowing:
‘‘SEC. 3. JOHN F. KENNEDY CENTER FOR THE PERFORMING
ARTS.
‘‘(a) IN GENERAL.—The Board’’; and
(2) by adding at the end the following:
‘‘(b) PARKING GARAGE ADDITIONS AND SITE IM-
PROVEMENTS.—
‘‘(1) IN GENERAL.—Substantially in accordance
with the plan entitled ‘Site Master Plan—Drawing
Number 1997–2 April 29, 1997,’ and map number
NCR 844/82571, the Board may design and con-
struct—
‘‘(A) an addition to the parking garage at
each of the north and south ends of the John
F. Kennedy Center for the Performing Arts;
and
‘‘(B) site improvements and modifications.
‘‘(2) AVAILABILITY.—The plan shall be on file
and available for public inspection in the office of
the Secretary of the Center.
‘‘(3) LIMITATION
ON
USE
OF
APPROPRIATED
FUNDS.—No appropriated funds may be used to pay
the costs (including the repayment of obligations in-
curred to finance costs) of—
‘‘(A) the design and construction of an ad-
dition to the parking garage authorized under
paragraph (1)(A);
‘‘(B) the design and construction of site
improvements and modifications authorized
under paragraph (1)(B) that the Board specifi-
cally designates will be financed using sources
other than appropriated funds; or
‘‘(C) any project to acquire large screen
format equipment for an interpretive theater, or
to produce an interpretive film, that the Board
specifically designates will be financed using
sources other than appropriated funds.’’.
SEC. 3. PEDESTRIAN AND VEHICULAR ACCESS.
(a) DUTIES OF THE BOARD.—Section 4(a)(1) of the
John F. Kennedy Center Act (20 U.S.C. 76j(a)(1)) is
amended—
(1) by striking ‘‘and’’ at the end of subpara-
graph (G);
(2) by striking the period at the end of sub-
paragraph (H) and inserting ‘‘; and’’; and
(3) by adding at the end the following:
‘‘(I) ensure that safe and convenient access
to the site of the John F. Kennedy Center for
the Performing Arts is provided for pedestrians
and vehicles.’’.
(b) POWERS OF THE BOARD.—Section 5 of such Act
(20 U.S.C. 76k) is amended by adding at the end the fol-
lowing:
‘‘(g) PEDESTRIAN AND VEHICULAR ACCESS.—Sub-
ject to approval of the Secretary of the Interior under sec-
tion 4(a)(2)(F), the Board shall develop plans and carry
out projects to improve pedestrian and vehicular access
to the John F. Kennedy Center for the Performing Arts.’’.
SEC. 4. DEFINITION OF BUILDING AND SITE.
Section 13 of the John F. Kennedy Center Act (20
U.S.C. 76s) and section 9(3) of the Act of October 24,
1951 (40 U.S.C. 193v), are each amended by inserting
after ‘‘numbered 844/82563, and dated April 20, 1994’’
the following: ‘‘(as amended by the map entitled ‘Transfer
of John F. Kennedy Center for the Performing Arts’,
numbered 844/82563A and dated May 22, 1997)’’.
Passed the House of Representatives June 17, 1997.
Attest:
Clerk.
Sec. 3002. Patient-focused drug development guidance. 
Sec. 3003. Streamlining patient input. 
Sec. 3004. Report on patient experience drug development. 
Subtitle B—Advancing New Drug Therapies 
Sec. 3011. Qualification of drug development tools. 
Sec. 3012. Targeted drugs for rare diseases. 
Sec. 3013. Reauthorization of program to encourage treatments for rare pediatric 
diseases. 
Sec. 3014. GAO study of priority review voucher programs. 
Sec. 3015. Amendments to the Orphan Drug grants. 
Sec. 3016. Grants for studying continuous drug manufacturing. 
Subtitle C—Modern Trial Design and Evidence Development 
Sec. 3021. Novel clinical trial designs. 
Sec. 3022. Real world evidence. 
Sec. 3023. Protection of human research subjects. 
Sec. 3024. Informed consent waiver or alteration for clinical investigations. 
Subtitle D—Patient Access to Therapies and Information 
Sec. 3031. Summary level review. 
Sec. 3032. Expanded access policy. 
Sec. 3033. Accelerated approval for regenerative advanced therapies. 
Sec. 3034. Guidance regarding devices used in the recovery, isolation, or delivery 
of regenerative advanced therapies. 
Sec. 3035. Report on regenerative advanced therapies. 
Sec. 3036. Standards for regenerative medicine and regenerative advanced thera-
pies. 
Sec. 3037. Health care economic information. 
Sec. 3038. Combination product innovation. 
Subtitle E—Antimicrobial Innovation and Stewardship 
Sec. 3041. Antimicrobial resistance monitoring. 
Sec. 3042. Limited population pathway. 
Sec. 3043. Prescribing authority. 
Sec. 3044. Susceptibility test interpretive criteria for microorganisms; anti-
microbial susceptibility testing devices. 
Subtitle F—Medical Device Innovations 
Sec. 3051. Breakthrough devices. 
Sec. 3052. Humanitarian device exemption. 
Sec. 3053. Recognition of standards. 
Sec. 3054. Certain class I and class II devices. 
Sec. 3055. Classification panels. 
Sec. 3056. Institutional review board flexibility. 
Sec. 3057. CLIA waiver improvements. 
Sec. 3058. Least burdensome device review. 
Sec. 3059. Cleaning instructions and validation data requirement. 
Sec. 3060. Clarifying medical software regulation.
100
official duties, in connection with the en-
forcement of United States narcotics laws
or the implementing of United States nar-
cotics control objectives; or
‘‘(II) a member of the immediate fam-
ily of any such individual on account of
that individual’s official duties, in connec-
tion with the enforcement of United States
narcotics laws or the implementing of
United States narcotics control objectives;
or
‘‘(iii) an attempt or conspiracy to commit
any of the acts described in clause (i) or (ii);
or
‘‘(D) the arrest or conviction in any country of
any individual aiding or abetting in the commission
of an act described in subparagraphs (A) through
(C); or
‘‘(E) the prevention, frustration, or favorable
resolution of an act described in subparagraphs (A)
through (C).
‘‘(c) COORDINATION.—(1) To ensure that the pay-
ment of rewards pursuant to this section does not dupli-
cate or interfere with the payment of informants or the
obtaining of evidence or information, as authorized to the
‘‘(HHH) 
(1–(5-fluoropentyl)–1H-indazol-3- 
yl)(naphthalene-1-yl)methanone. 
‘‘(III) 
1-[(1-methyl-2-piperidinyl)methyl]-1H- 
indol-3-yl](2,2,3,3- 
tetramethylcyclopropyl)methanone. 
‘‘(JJJ) 
(1–(1-methylazepan-2-yl)–1H-indol-3- 
yl)(2,2,3,3-tetramethylcyclopropyl)methanone. 
‘‘(KKK) 4-hydroxy-3,3,4-trimethyl-1–(1-pentyl- 
1H-indol-3-yl)pentan-1-one. 
‘‘(LLL) 
[1–(4-fluoropentyl)–1H-indol-3-yl]-1- 
naphthenyl-methanone. 
‘‘(MMM) 
2–(2-iodophenyl)–1–(1-pentyl-1H- 
indol-3-yl)ethanone. 
‘‘(NNN) 
(1-hexyl-1H-indol-3-yl)(2,2,3,3- 
tetramethylcyclopropyl)methanone. 
‘‘(OOO) 
(2,2,3,3-tetramethylcyclopropyl)[1– 
(4,4,4-trifluorobutyl)–1H-indol-3-yl]methanone. 
‘‘(PPP) 
7-methoxy-1–(2-morpholinoethyl)–N– 
((1S,4R)–1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)– 
1H-indole-3-ca rboxamide. 
‘‘(QQQ) quinolin-8-yl 1–(4-fluorobenzyl)–1H- 
indole-3-carboxylate. 
‘‘(RRR) 
naphthalen-1-yl 
1–(4-fluorobenzyl)– 
1H-indole-3-carboxylate. 
VerDate Sep 11 2014 
01:09 Sep 22, 2015
Jkt 049200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H3537.IH
H3537
SSpencer on DSK4SPTVN1PROD with BILLS
‘‘(SSS) N–(1-amino-3,3-dimethyl-1-oxobutan-2- 
yl)–1-pentyl-1H-indazole-3-carboxamide. 
‘‘(TTT) N–(1-amino-3,3-dimethyl-1-oxobutan-2- 
yl)–1–(5-fluoropentyl)–1H-indole-3-carboxamide. 
‘‘(UUU) 
(1–(4-fluoropentyl)–1H-indol-3- 
yl)(2,2,3,3-tetramethylcyclopropyl)methanone. 
‘‘(VVV) 1-naphthalenyl(1-pentyl-1H-indazol-3- 
yl)methanone. 
‘‘(WWW) N-naphthalenyl-1-pentyl-1H-indazole- 
3-carboxamide. 
‘‘(XXX) 
N–(1-amino-3-methyl-1-oxobutan-2- 
yl)–1–(cyclohexyl 
methyl)–1H-indazole-3- 
carboxamide. 
‘‘(YYY) naphthalene-1-yl(9-pentyl-9H-carbazol- 
3-yl)methanone. 
‘‘(ZZZ) naphthalene-1-yl 
1–(5-fluoropentyl)– 
1H-indole-3-carboxylate. 
‘‘(AAAA) methyl 3-methyl-2–(1-pentyl-1H-inda-
zole-3-carboxamido. 
‘‘(BBBB) methyl 2–(1–5-fluoropentyl)–1H-in-
dazole-3-caboxamido)–3-methylbutanoate. 
‘‘(CCCC) 
N-benzyl-1-pentyl-1H-indole-3- 
carboxamide. 
‘‘(DDDD) 
N-benzyl-1–(5-fluoropentyl)–1H- 
indole-3-carboxamide. 
VerDate Sep 11 2014 
01:09 Sep 22, 2015
Jkt 049200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H3537.IH
H3537
SSpencer on DSK4SPTVN1PROD with BILLS
HR 1796 IH
North Carolina; and the Mountain Warfare Training Cen-
ter, Bridgeport, California);
‘‘Military 
Personnel, 
Marine 
Corps’’,
$4,000,000;
‘‘Operation and Maintenance, Marine Corps’’,
$11,000,000;
‘‘Procurement of Ammunition, Navy and Ma-
rine Corps, 1996/1998’’, $4,000,000; and
‘‘Procurement, Marine Corps, 1996/1998’’,
$4,000,000.
SEC. 102. In addition to the amounts appropriated
in title VI of the Department of Defense Appropriations
Act, 1997 (as contained in section 101(b) of Public Law
104–208), under the heading ‘‘Defense Health Program’’,
$21,000,000 is hereby appropriated and made available
only for the provision of direct patient care at military
treatment facilities.
SEC. 103. In addition to the amounts appropriated
in title II of the Department of Defense Appropriations
Act, 1997 (as contained in section 101(b) of Public Law
104–208), under the heading ‘‘Operation and Mainte-
nance, Defense-Wide’’, $10,000,000 is hereby appro-
priated and made available only for force protection and
counter-terrorism initiatives.
II
Calendar No. 89
105TH CONGRESS
1ST SESSION
H. R. 1747
IN THE SENATE OF THE UNITED STATES
JUNE 18 (legislative day, JUNE 17), 1997
Received
JUNE 19, 1997
Read twice and placed on the calendar
AN ACT
To amend the John F. Kennedy Center Act to authorize
the design and construction of additions to the parking
garage and certain site improvements, and for other pur-
poses.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
218 
‘‘(A) the Secretary’s determination that 
such a standard is not applicable to a particular 
drug because the characteristics of the drug differ 
from other drugs with the same active ingredient; 
‘‘(B) information provided by interested 
third parties, including public comment on the 
annual compilation of notices published under 
paragraph (3); 
‘‘(C) any bases used to identify suscepti-
bility test interpretive criteria under subsection 
(a)(2); and 
‘‘(D) such other information or factors as 
the Secretary determines appropriate. 
‘‘(3) ANNUAL COMPILATION OF NOTICES.—Each 
year, the Secretary shall compile the notices published 
under paragraph (1)(A) and publish such compila-
tion in the Federal Register and provide for public 
comment. If the Secretary receives comments, the Sec-
retary shall review such comments and, if the Sec-
retary determines appropriate, update pursuant to 
this subsection susceptibility test interpretive criteria 
standards or criteria— 
‘‘(A) recognized by the Secretary under this 
subsection; or